ConductScience.org, home

Paper8554944

The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteers.

Roberts J and 4 others. Br J Clin Pharmacol, 1995. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteers. Papers, record 8554944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8554944

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of selegiline on the peripheral pharmacokinetics of levodopa in young volunteers.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.29
iCite
Revised in PubMed
2019-05-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roberts JJ
2Waller DGD G
3O'Shea NN
4Macklin BSB S
5Renwick AGA G

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiparkinson AgentsMajor topic
LevodopaMajor topic
SelegilineMajor topic
Adult
Drug Interactions
Humans
Infusions, Intravenous
Male
Placebos
Reference Values

Source PubMed

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,528,851Variability of L-dopa absorption in man.Aust N Z J Med1974https://conductscience.org/library/papers/4528851PubMed
28,000,101Selegiline (L-deprenyl) and L-dopa treatment of Parkinson's disease: a double-blind trial.Intern Med1994https://conductscience.org/library/papers/8000101PubMed
36,420,516Changes in dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in human cerebrospinal fluid after L-dopa and deprenyl administration.J Neural Transm1983https://conductscience.org/library/papers/6420516PubMed
43,109,430Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.Biochem Pharmacol1987https://conductscience.org/library/papers/3109430PubMed
53,324,948On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics.Ann Neurol1987https://conductscience.org/library/papers/3324948PubMed
62,775,615The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2775615PubMed
72,404,503The influence of levodopa on gastric emptying in man.Br J Clin Pharmacol1990https://conductscience.org/library/papers/2404503PubMed
82,515,716Selegiline in the treatment of daily fluctuations in disability of parkinsonian patients with long-term levodopa treatment.Acta Neurol Scand Suppl1989https://conductscience.org/library/papers/2515716PubMed
92,106,391L-deprenyl, levodopa pharmacokinetics, and response fluctuations in Parkinson's disease.Clin Neuropharmacol1990https://conductscience.org/library/papers/2106391PubMed
101,549,214Deprenyl effects on levodopa pharmacodynamics, mood, and free radical scavenging.Neurology1992https://conductscience.org/library/papers/1549214PubMed
111,801,539Experience with selegiline and levodopa in advanced Parkinson's disease.Acta Neurol Scand Suppl1991https://conductscience.org/library/papers/1801539PubMed
121,513,186Pharmacological basis of the therapeutic effect of (-)deprenyl in age-related neurological diseases.Med Res Rev1992https://conductscience.org/library/papers/1513186PubMed
138,422,661Effects of selegiline dosing on motor fluctuations in Parkinson's disease.Clin Neuropharmacol1993https://conductscience.org/library/papers/8422661PubMed
148,477,410The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers.Clin Neuropharmacol1993https://conductscience.org/library/papers/8477410PubMed
158,290,096Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in parkinsonian patients.Neurology1994https://conductscience.org/library/papers/8290096PubMed
168,302,307Selegiline in de novo parkinsonian patients: the Finnish study.Mov Disord1993https://conductscience.org/library/papers/8302307PubMed
177,202,139Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient.Neurology1981https://conductscience.org/library/papers/7202139PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
41,735,694Estimating Human Jejunal Effective Permeability Using Numerical Deconvolution of Oral Solution Concentration Data.Pharm Res2026https://conductscience.org/library/papers/41735694PubMed
27,521,014Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.CNS Drugs1998https://conductscience.org/library/papers/27521014PubMed
26,779,024The Human Experience with Intravenous Levodopa.Front Pharmacol2015https://conductscience.org/library/papers/26779024PubMed
16,485,914Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.Clin Pharmacokinet2006https://conductscience.org/library/papers/16485914PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8554944

GET https://conductscience.org/api/papers/v1/8554944/authors